Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-17

Clinical Trial Update: Treating Depression With Transcutaneous Electrical Cranial-auricular Acupoint Stimulation (TECAS). [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluating transcutaneous electrical cranial-auricular acupoint stimulation for mild-to-moderate depression have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Hong Kong | Conditions: Mild-to-moderate Depression | Phase 2, Phase 3 | Status: COMPLETED